| Literature DB >> 34158517 |
Anna Jaeger1,2, Malte Posselt3, Jonas L Schaper4, Andrea Betterle5, Cyrus Rutere6, Claudia Coll3, Jonas Mechelke7,8, Muhammad Raza9,10, Karin Meinikmann11, Andrea Portmann12, Phillip J Blaen13,14, Marcus A Horn6,15, Stefan Krause13,16, Jörg Lewandowski17,18.
Abstract
Urban streams receive increasing loads of organic micropollutants from treated wastewaters. A comprehensive understanding of the in-stream fate of micropollutants is thus of high interest for water quality management. Bedforms induce pumping effects considerably contributing to whole stream hyporheic exchange and are hotspots of biogeochemical turnover processes. However, little is known about the transformation of micropollutants in such structures. In the present study, we set up recirculating flumes to examine the transformation of a set of micropollutants along single flowpaths in two triangular bedforms. We sampled porewater from four locations in the bedforms over 78 days and analysed the resulting concentration curves using the results of a hydrodynamic model in combination with a reactive transport model accounting for advection, dispersion, first-order removal and retardation. The four porewater sampling locations were positioned on individual flowpaths with median solute travel times ranging from 11.5 to 43.3 h as shown in a hydrodynamic model previously. Highest stability was estimated for hydrochlorothiazide on all flowpaths. Lowest detectable half-lives were estimated for sotalol (0.7 h) and sitagliptin (0.2 h) along the shortest flowpath. Also, venlafaxine, acesulfame, bezafibrate, irbesartan, valsartan, ibuprofen and naproxen displayed lower half-lives at shorter flowpaths in the first bedform. However, the behavior of many compounds in the second bedform deviated from expectations, where particularly transformation products, e.g. valsartan acid, showed high concentrations. Flowpath-specific behavior as observed for metformin or flume-specific behavior as observed for metoprolol acid, for instance, was attributed to potential small-scale or flume-scale heterogeneity of microbial community compositions, respectively. The results of the study indicate that the shallow hyporheic flow field and the small-scale heterogeneity of the microbial community are major controlling factors for the transformation of relevant micropollutants in river sediments.Entities:
Year: 2021 PMID: 34158517 PMCID: PMC8219703 DOI: 10.1038/s41598-021-91519-2
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Schematic of Flumes 1 and 2. Flume 1 held porewater samplers in positions A, B, C and D. Flume 2 held porewater samplers in positions B and D. The measures represent ideal conditions obtained after bedform formation. Figure adapted from Jaeger et al.[35].
Boundary conditions of Flumes 1 and 2, as well as shared sediment properties (mean ± sd).
| Flume 1 | Flume 2 | Days of measurement | |
|---|---|---|---|
| Surface water flow velocity at the bedform side of the flume [cm s−1] | 7.0 ± 1.8 | 7.2 ± 0.3 | 27, 47, 82 |
| Drop of bedform heights by day 27 [%] | 4 | 5 | 27 |
| Drop of bedform heights by day 82 [%] | 32 | 33 | 82 |
| Water level [cm] | 11.3 ± 0.2 | 11.4 ± 0.3 | 27, 47, 82 |
| pH | 8.3 | 8.3 | − 4, 45 |
| O2 in the surface water [%] | 101.8 ± 5.9 | 103.1 ± 5.9 | 28, 36, 44, 82 |
| Sediment composition | 2.13 kg sand + 2 L Erpe sediment | Measurements performed with initial sediment mixtures | |
| Kf at 10 °C [m s−1] | 3.14 × 10−4 ± 4% | ||
| Porosity [%] | 35 | ||
| Total carbon [%] | 0.01 | ||
| Fine gravel (2–6.3 mm) [%] | 5 | ||
| Coarse sand (0.63–2 mm) [%] | 6 | ||
| Medium sand (0.2–0.63 mm) [%] | 82 | ||
| Fine sand (0.063–0.2 mm) [%] | 6 | ||
| < 0.063 mm [%] | < 1 | ||
Figure 2Measured concentrations in the SW, in PW Samplers A, B, C and D in Flume 1 and PW Samplers B and D in Flume 2 of selected compounds and related TPs. Grey vertical lines indicate sampling days. Note the differences in scales of the x- and y-axes. For concentrations of all compounds see Supplementary Fig. S1 (78 days) and Fig. S2 (7 days).
Figure 3Boxplots of concentrations of NH4+, PO43− and DOC in the SW, in Bedform 1 (Samplers A, B, and C) and Bedform 2 (Sampler D) of Flumes 1 and 2 aggregated over the PW sampling days 0, 21, 42 and 78 (n = 4).
Figure 4Bacterial community composition at the phylum level in relative abundance values (%) in Flumes 1 and 2 sampled at days 0, 21 and 56, respectively. Samples were taken from the flat sediment area in the flumes.
Figure 5Top: Trajectories of particles along Flowpaths a, b, c and d in Bedforms 1 and 2 calculated by the hydrodynamic model. Bottom: Distribution and median values of flowpath lengths and travel times from SW to PW Samplers A, B, C and D. Figure adapted from Betterle et al.[38].
Medians of parameter estimates for half-lives (DT50s) and retardation coefficients R of selected parent compounds and respective inter quartile ranges (in brackets) on Flowpaths a, b, c and d of Flume 1, as well as average root mean square errors (RMSE).
| Compound | Retardation coefficient R [–] | Half-life DT50 [h] | RMSE | ||||||
|---|---|---|---|---|---|---|---|---|---|
| a | b | c | d | a | b | c | d | average | |
| 1H-Benzotriazole | 1.76 (1.14) | 1.91 (0.22) | 1.90 (0.11) | 1.41 (0.09) | 53.5 (39.5) | 97.3 (42.8) | 287 (208) | Inf | 0.464 |
| Acesulfame | 1.10 (0.13) | 1.00 (0.00) | 1.00 (0.00) | 1.00 (0.01) | 6.63 (0.58) | 36.6 (2.45) | 54.0 (3.34) | 54.4 (5.65) | 1.498 |
| Bezafibrate | 1.09 (0.14) | 1.01 (0.02) | 1.28 (0.03) | 1.05 (0.05) | 7.43 (1.05) | 36.9 (4.29) | 87.5 (13.7) | 92.4 (25.9) | 0.962 |
| Carbamazepine | 2.63 (1.31) | 1.61 (0.11) | 1.98 (0.06) | 1.39 (0.07) | 49.0 (39.4 | 106 (39.2) | 284.6(196) | 85.1 (26.6) | 0.839 |
| Clofibric acid | 2.53 (0.84) | 1.02 (0.02) | 1.17 (0.02) | 1.23 (0.04) | Inf | Inf | Inf | Inf | 0.904 |
| Diclofenac | 5.05 (1.11) | 1.39 (0.09) | 1.11 (0.03) | 1.17 (0.05) | Inf | 44.3 (5.15) | 139 (29.9) | 142 (53.0) | 0.913 |
| Furosemide | 7.58 (9.09) | 1.17 (0.28) | 1.42 (0.16) | 1.26 (0.16) | Inf | 37.0 (10.8) | 163 (125) | Inf | 2.547 |
| Gemfibrozil | 2.62 (0.61) | 1.12 (0.07) | 1.35 (0.03) | 1.31 (0.03) | Inf | 154 (39.8) | 273 (76.6) | 196 (71.3) | 0.278 |
| Hydrochlorothiazide | 1.29 (0.44) | 1.13 (0.08) | 1.41 (0.04) | 1.21 (0.03) | Inf | Inf | Inf | Inf | 0.733 |
| Ibuprofen | 5.62 (5.04) | 1.20 (0.24) | 1.07 (0.11) | 1.11 (0.13) | 3.71 (1.31) | 24.7 (6.12) | 53.6 (15.8) | 58.3 (31.0) | 1.728 |
| Irbesartan | 1.53 (0.83) | 2.42 (0.23) | 1.91 (0.04) | 1.38 (0.03) | 3.25 (0.32) | 5.06 (0.20) | 93.1 (10.7) | 75.6 (11.9) | 0.819 |
| Ketoprofen | 1.30 (0.42) | 1.03 (0.04) | 1.30 (0.05) | 1.04 (0.06) | 21.1 (7.91) | Inf | 63.5 (10.6) | 75.7 (26.5) | 1.603 |
| Metformin | 10.6 (1.07) | 8.03 (0.28) | 4.31 (0.17) | 4.46 (0.09) | 28.3 (6.56) | 136 (50.2) | 20.0 (0.71) | 36.7 (3.39) | 0.340 |
| Naproxen | 4.76 (1.05) | 1.05 (0.06) | 1.03 (0.04) | 1.01 (0.02) | 30.1 (12.9) | 65.4 (12.9) | 67.7 (8.24) | Inf | 1.358 |
| Sitagliptin | 5.25 (11.6) | 11.8 (4.62) | 7.42 (0.99) | 12.8 (29.0) | 0.19 (0.02) | 4.99 (0.76) | 13.9 (2.13) | 5.86 (1.72) | 0.113 |
| Sotalol | 8.09 (4.88) | 3.48 (0.28) | 2.83 (0.28) | 1.89 (0.10) | 0.67 (0.10) | 6.89 (0.41) | 12.0 (1.55) | 6.43 (0.24) | 0.072 |
| Sulfamethxazole | 3.78 (1.79) | 1.10 (0.12) | 1.28 (0.05) | 1.22 (0.09) | Inf | 56.3 (13.7) | 29.1 (2.15) | Inf | 0.606 |
| Valsartan | 2.26 (0.84) | 1.16 (0.14) | 1.23 (0.03) | 1.01 (0.01) | 6.37 (0.83) | 7.51 (0.27) | 74.2 (8.46) | 39.7 (4.38) | 1.028 |
| Venlafaxine | 47.6 (2.10) | 12.4 (2.71) | 9.23 (1.58) | 12.9 (1.34) | 0.97 (0.12) | 3.59 (0.33) | 8.17 (1.35) | 4.79 (0.32) | 0.620 |
DT50s exceeding the thresholds (Supplementary Table S4) were set to infinity (inf). For respective values of degradation rate constants k, see Supplementary Table S3.
Figure 6Measured concentrations and modeled breakthrough curves of metformin and hydrochlorothiazide in Flume 1. To the right, the estimated posterior distributions (n = 40,040) of the degradation rate constant k and the retardation coefficient R are given for each Flowpath a, b, c and d. For model results of all analysed compounds see Supplementary Figs. S5, S6, S7 and S8.